Page last updated: 2024-08-24

capecitabine and Inflammatory Breast Cancer

capecitabine has been researched along with Inflammatory Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Corral de la Fuente, E; Fernández Abad, M; Martin Huertas, R; Martínez Jáñez, N; Serrano Domingo, JJ1
Kumar, PV; Prabaharan, S; Ravind, R1

Other Studies

2 other study(ies) available for capecitabine and Inflammatory Breast Cancer

ArticleYear
Early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: Ten years of complete response.
    The breast journal, 2020, Volume: 26, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Female; Fluorouracil; Humans; Inflammatory Breast Neoplasms; Lapatinib; Neoplasm Recurrence, Local; Receptor, ErbB-2; Trastuzumab; Treatment Outcome

2020
Inflammatory breast cancer in a previously treated case of breast cancer: a diagnostic dilemma for the clinician.
    BMJ case reports, 2016, Apr-08, Volume: 2016

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Female; Humans; Inflammatory Breast Neoplasms; Lapatinib; Middle Aged; Neoplasms, Second Primary; Paclitaxel; Prognosis; Quinazolines

2016